A preclinical study on human breast cancer cells found that S1PR1 antibody can enhance the cytotoxic and anti-proliferative effect of carboplatin on MDA-MB-231 and SK-BR-3 (HER2 subtype) cells, respectively [16]. Here, S1PR1 is linked to breast carcinoma.